Rigel Pharmaceuticals (RIGL) Change in Intangibles (2023 - 2024)
Rigel Pharmaceuticals (RIGL) recorded quarterly Change in Intangibles of $222000.0 in Q2 2024, up 60.87% quarter-over-quarter from $138000.0 in Q1 2024.
Rigel Pharmaceuticals (RIGL) Change in Intangibles (2023 - 2024) Analysis & Trends
Rigel Pharmaceuticals' Change in Intangibles history runs 2 years deep, the most recent figure standing at $222000.0 for Q2 2024.
- In Q2 2024, Change in Intangibles changed N/A year-over-year to $222000.0; the TTM figure through Dec 2024 stood at $360000.0 (down 97.6% YoY), while the FY2024 annual figure was $360000.0, down 97.6% from the prior year.
- Change in Intangibles was $222000.0 for Q2 2024 at Rigel Pharmaceuticals, up from $138000.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $15.0 million in Q1 2023 to a low of $138000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 603.18 Mn | 456.49 Mn | 54.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 222,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Mar 31, 2024 | 138,000.00 |
| Mar 31, 2023 | 15.00 Mn |
| Mar 31, 2023 | 15.00 Mn |